AI Human Genetics Platform Mystra Debuts for Drug Discovery, Validation
Officially unveiled at the American Society of Human Genetics (ASHG) 2025 meeting held in Boston, Genomics has launched…
AI Model Finds Gene Targets and Drug Combos to Reprogram Diseased Cells
Credit: FlashMovie/Getty Images Traditional drug discovery has often followed the “one drug, one target” paradigm—developing compounds against individual…
Synthetic Metagenomic Method Uncovers Genetic Drivers of Antimicrobial Resistance
Antimicrobial resistance studies often focus on individual protein variants, neglecting broader protein family dynamics. Dihydrofolate reductase (DHFR), a…
![An AI-designed protein binder (purple and pink) envelops the flexible hormone amylin (white), preventing it from forming toxic fibrils linked to type 2 diabetes in lab tests. [Ian Haydon]](https://www.newsbeep.com/uk/wp-content/uploads/2025/07/diffused-amylin-binder-UW-IPD-380x220.jpg)
AI Hits Disordered Proteins, Unlocks Therapy Targets
Drug developers have historically glued their attention to targeting the precise and fine-tuned protein structures underlying biological function.…